Aker BioMarine (OB:AKBM) - Hisse Senedi Fiyatı, Haberler ve Analizler

AKBM Stoklara Genel Bakış

Aker BioMarine AS, kril hasadı yapmakta ve dünya çapında kril türevi ürünler tedarik etmektedir.

AKBM temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	3/6
Geçmiş Performans	3/6
Finansal Sağlık	4/6
Temettüler	2/6

Ödüller

Adil değer tahminimizden 73% daha düşük bir oranda işlem görüyor

Kazançların yılda 100.65% oranında artması öngörülüyor

Bu yıl karlı hale geldi

Risk Analizi

Faiz ödemeleri kazançlarla iyi karşılanmıyor

Son 3 ayda hisse senedi fiyatı oldukça dalgalıydı

Aker BioMarine AS Rakipler

Kaldvik

OB:KLDVK

NOK 3.3b

Måsøval

OB:MAS

NOK 3.4b

Austevoll Seafood

OB:AUSS

NOK 19.4b

Lerøy Seafood Group

OB:LSG

NOK 30.6b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Aker BioMarine
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	NOK 47.65
52 Haftanın En Yüksek Seviyesi	NOK 109.80
52 Haftanın En Düşük Seviyesi	NOK 39.55
Beta	0.88
11 Aylık Değişim	-1.75%
3 Aylık Değişim	-50.42%
1 Yıllık Değişim	13.45%
33 Yıllık Değişim	11.99%
5 Yıllık Değişim	n/a
Halka arzdan bu yana değişim	-54.49%

Son Haberler & Güncellemeler

Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

Nov 05

At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Aug 20

Recent updates

Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

Nov 05

At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Aug 20

Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

Jul 19

What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

Jul 16

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Jul 11

These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

Jun 03

There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

Feb 15

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Nov 06

Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

Sep 06

We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Nov 04

Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Apr 13

Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Feb 18

Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Jan 07

Hissedar Getirileri

	AKBM	NO Food	NO Pazar
7D	-7.1%	-1.4%	-3.1%
1Y	13.5%	12.3%	0.8%

Getiri vs. Endüstri: AKBM geçen yıl % 12.3 oranında getiri sağlayan Norwegian Food sektörünün gerisinde kaldı.

Getiri vs Piyasa: AKBM geçen yıl % 0.8 oranında getiri sağlayan Norwegian Piyasasını aştı.

Fiyat Oynaklığı

Is AKBM's price volatile compared to industry and market?
AKBM volatility
AKBM Average Weekly Movement	13.8%
Food Industry Average Movement	5.0%
Market Average Movement	5.0%
10% most volatile stocks in NO Market	10.6%
10% least volatile stocks in NO Market	2.6%

İstikrarlı Hisse Senedi Fiyatı: AKBM hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: AKBM 'nin haftalık oynaklığı geçtiğimiz yıl boyunca 9% dan 14% a yükseldi.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
2006	373	Matts Johansen	www.akerbiomarine.com

Aker BioMarine AS, kril hasadı yapmakta ve dünya çapında kril türevi ürünler tedarik etmektedir. Şirket, Malzemeler ve Markalar olmak üzere iki segmentte faaliyet göstermektedir. Bileşenler segmenti, nutrasötik, evcil hayvan maması ve su ürünleri yetiştiriciliği endüstrileri için kril türevi ürünlerin açık deniz hasadı ve üretimi, lojistik operasyonları ve kara üretimi ve satışı ile ilgilenmektedir.

Aker BioMarine AS Temel Bilgiler Özeti

Aker BioMarine'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
AKBM temel i̇stati̇sti̇kler
Piyasa değeri	NOK 4.18b
Kazançlar(TTM)	NOK 28.79m
Gelir(TTM)	NOK 3.71b

145.1x

F/K Oranı

1.1x

P/S Oranı

AKBM aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
AKBM gelir tablosu (TTM)
Gelir	US$334.80m
Gelir Maliyeti	US$225.90m
Brüt Kâr	US$108.90m
Diğer Giderler	US$106.30m
Kazançlar	US$2.60m

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	0.03
Brüt Marj	32.53%
Net Kâr Marjı	0.78%
Borç/Özkaynak Oranı	79.2%

AKBM uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

94.4%

Mevcut Temettü Verimi

n/a

Ödeme Oranı

AKBM Stoklara Genel Bakış

Ödüller

Risk Analizi

Aker BioMarine AS Rakipler

OB:KLDVK

NOK 3.3b

OB:MAS

NOK 3.4b

OB:AUSS

NOK 19.4b

OB:LSG

NOK 30.6b

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

New major risk - Financial position

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Share price stability

Aker BioMarine AS Announces Extraordinary Dividend, Payable on 30 September 2024

At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Recent updates

Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

New major risk - Financial position

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Share price stability

Aker BioMarine AS Announces Extraordinary Dividend, Payable on 30 September 2024

At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

Second quarter 2024 earnings released: US$0.03 loss per share (vs US$0.005 profit in 2Q 2023)

Aker BioMarine AS Expects to Pay Extraordinary Dividend

Aker BioMarine AS Expects to Pay Extraordinary Dividend

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Aker BioMarine Antarctic Holding II AS completed the acquisition of Feed Ingredients business of Aker BioMarine AS (OB:AKBM).

AIP, LLC and Aker Capital ASA agreed to acquire Feed Ingredients business from Aker BioMarine AS (OB:AKBM).

AIP, LLC and Aker Capital ASA agreed to acquire Feed Ingredients business from Aker BioMarine AS (OB:AKBM).

These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

First quarter 2024 earnings released: US$0.07 loss per share (vs US$0.20 loss in 1Q 2023)

Consensus EPS estimates fall by 69%

Full year 2023 earnings: EPS exceeds analyst expectations

Full year 2023 earnings released: US$0.10 loss per share (vs US$0.11 profit in FY 2022)

There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Third quarter 2023 earnings released: US$0.01 loss per share (vs US$0.05 profit in 3Q 2022)

Aker BioMarine AS to Report Q1, 2024 Results on Apr 25, 2024

No independent directors

Aker BioMarine ASA Receives Approval for LYSOVETA as New Dietary Suppient in the US

Aker BioMarine AS Provides Revenue Guidance for the Full Year of 2023

Aker BioMarine AS Provides Revenue Guidance for the Full Year of 2023

Consensus EPS estimates fall from profit to US$0.086 loss, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates increase by 308%

Consensus EPS estimates fall by 65%

Chairman recently bought kr5.4m worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Aker BioMarine ASA Announces Ministry of Food and Drug Safety in South Korea Approves Superba Krill Oil

Chief Executive Officer recently bought kr305k worth of stock

No independent directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus forecasts updated

Consensus EPS estimates increase by 57%

Now 20% undervalued

Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

Consensus EPS estimates increase by 136%

Consensus forecasts updated

Aker Biomarine as Reiterates Earnings Guidance for the Full Year of 2022

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Aker BioMarine AS Appoints Mr. Øyvind Eriksen as an Observer to the Board on June 8, 2022

Now 20% undervalued

Forecast breakeven date moved forward to 2022

Now 22% undervalued

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

No independent directors

Aker Biomarine AS Announces Board Changes

Full year 2021 earnings: EPS and revenues miss analyst expectations

Aker BioMarine AS, Annual General Meeting, Apr 20, 2022

Aker BioMarine AS, Annual General Meeting, Apr 20, 2022

Consensus forecasts updated

Forecast breakeven date moved forward to 2022

Forecast breakeven date moved forward to 2022